This is believed to be due to selective pressure by the CAR T cells for cancer cells with increasing expression of mutated or truncated variants of CD19, ultimately leading to a subpopulation of cancer cells not detected by the CAR T cells [59]. This evidence concerns the gene CD19 and cancer.